iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.75+0.04 (+5.86%)
Close on Nov 17, 2026Market cap $48.11MP/E –Yield –
iBio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
iBio's total debt was $643.00K at Dec 31, 2024. For fiscal 2024 it was $766.00K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $766.00K | – |
| FY2021 | Jun 30, 2021 | $0 | -100.0% |
| FY2020 | Jun 30, 2020 | $339.00K | – |
| FY2019 | Jun 30, 2019 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $643.00K | -97.1% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $706.00K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $766.00K | +2152.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $22.12M | +16285.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $22.05M | +9166.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $0 | -100.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $34.00K | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $135.00K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $238.00K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $339.00K | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $0 | – |
See a number that looks wrong?